| Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on … ALP Caforio, S Pankuweit, E Arbustini, C Basso, J Gimeno-Blanes, ... European heart journal 34 (33), 2636-2648, 2013 | 3181 | 2013 |
| European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis … AL Caforio, S Pankuweit, E Arbustini, C Basso, J Gimeno-Blanes, SB Felix, ... Eur Heart J 34 (33), 2636-48, 2013 | 630 | 2013 |
| Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases P Charron, M Arad, E Arbustini, C Basso, Z Bilinska, P Elliott, T Helio, ... European heart journal 31 (22), 2715-2726, 2010 | 564 | 2010 |
| Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and … C Rapezzi, E Arbustini, ALP Caforio, P Charron, J Gimeno-Blanes, ... European heart journal 34 (19), 1448-1458, 2013 | 474 | 2013 |
| Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography L Faber, H Seggewiss, U Gleichmann Circulation 98 (22), 2415-2421, 1998 | 471 | 1998 |
| Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients C Knight, AS Kurbaan, H Seggewiss, M Henein, M Gunning, D Harrington, ... Circulation 95 (8), 2075-2081, 1997 | 449 | 1997 |
| Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients H Seggewiss, U Gleichmann, L Faber, D Fassbender, HK Schmidt, ... Journal of the American College of Cardiology 31 (2), 252-258, 1998 | 378 | 1998 |
| Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology PM Seferović, M Polovina, J Bauersachs, M Arad, T Ben Gal, LH Lund, ... European journal of heart failure 21 (5), 553-576, 2019 | 332 | 2019 |
| Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases AD Ristić, M Imazio, Y Adler, A Anastasakis, LP Badano, A Brucato, ... European heart journal 35 (34), 2279-2284, 2014 | 238 | 2014 |
| Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients L Faber, A Meissner, P Ziemssen, H Seggewiss Heart 83 (3), 326-331, 2000 | 228 | 2000 |
| Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry J Veselka, MK Jensen, M Liebregts, J Januska, J Krejci, T Bartel, ... European heart journal 37 (19), 1517-1523, 2016 | 195 | 2016 |
| Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience L Faber, H Seggewiss, D Welge, D Fassbender, HK Schmidt, ... European Journal of Echocardiography 5 (5), 347-355, 2004 | 186 | 2004 |
| Hypertrophic obstructive cardiomyopathy: surgical myectomy and septal ablation RA Nishimura, H Seggewiss, HV Schaff Circulation research 121 (7), 771-783, 2017 | 158 | 2017 |
| Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy H Seggewiss, L Faber, U Gleichmann The Thoracic and cardiovascular surgeon 47 (02), 94-100, 1999 | 136 | 1999 |
| Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) Registry R Zahn, T Ischinger, M Hochadel, U Zeymer, W Schmalz, N Treese, ... European heart journal 28 (3), 370-375, 2007 | 125 | 2007 |
| One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response L Faber, D Welge, D Fassbender, HK Schmidt, D Horstkotte, H Seggewiss Clinical Research in Cardiology 96, 864-873, 2007 | 112 | 2007 |
| Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring L Faber, P Ziemssen, H Seggewiss Journal of the American Society of Echocardiography 13 (12), 1074-1079, 2000 | 110 | 2000 |
| Survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy A Batzner, B Pfeiffer, A Neugebauer, D Aicha, C Blank, H Seggewiss Journal of the American College of Cardiology 72 (24), 3087-3094, 2018 | 107 | 2018 |
| Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy H Seggewiss, A Rigopoulos, D Welge, P Ziemssen, L Faber Clinical Research in Cardiology 96, 856-863, 2007 | 106 | 2007 |
| Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy H Seggewiss Current cardiology reports 3 (2), 160-166, 2001 | 98 | 2001 |
